High frequency CD8+PD-1+ TCR clonotypes isolated from fresh melanomas display anti-tumor activity

Similar Items

• Tumor- and neoantigen-reactive T-cell receptors can be identified based on their frequency in fresh tumor
  od: Pasetto, Anna, i dr.
  Izdano: (2016)
• Selection of circulating PD-1+ lymphocytes from cancer patients enriches for tumor-reactive and mutation-specific lymphocytes
  od: Gros, Alena, i dr.
  Izdano: (2015)
• Tumor-infiltrating human CD4(+) regulatory T cells display a distinct TCR repertoire and exhibit tumor and neoantigen reactivity
  od: Ahmadzadeh, Mojgan, i dr.
  Izdano: (2019)
• Isolation of T-Cell Receptors Specifically Reactive with Mutated Tumor-Associated Antigens from Tumor-Infiltrating Lymphocytes Based on CD137 Expression
  od: Parkhurst, Maria, i dr.
  Izdano: (2016)
• Use of CD137 up-regulation to identify T cell receptors specifically reactive with mutated tumor associated antigens from tumor infiltrating lymphocytes
  od: Parkhurst, Maria, i dr.
  Izdano: (2015)